Browse by People

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.

Collapse authors list.
Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J et al (show 24 more authors) , Darby, S, Meyer, T, Gillmore, R, Anthoney, A, Lind, P, Glimelius, B, Falk, S, Izbicki, JR, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Ma, YT, Patel, K, Sherriff, D, Soomal, R, Borg, D, Sothi, S, Hammel, P, Hackert, T, Jackson, R and Büchler, MW (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.

Collapse authors list.
Sheel, ARG, Harrison, S, Sarantitis, I ORCID: 0000-0002-3905-1417, Nicholson, JA, Hanna, T, Grocock, C, Raraty, M, Ramesh, J, Farooq, A, Costello, E et al (show 14 more authors) , Jackson, R, Chapman, M, Smith, A, Carter, R, Mckay, C, Hamady, Z, Aithal, GP, Mountford, R, Ghaneh, P, Hammel, P, Lerch, MM, Halloran, C ORCID: 0000-0002-5471-4178, Pereira, SP and Greenhalf, W (2019) Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. The American Journal of Gastroenterology (Elsevier), 114 (1). pp. 155-164.